These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11742676)

  • 1. Full-speed mammalian genetics: in vivo target validation in the drug discovery process.
    Abuin A; Holt KH; Platt KA; Sands AT; Zambrowicz BP
    Trends Biotechnol; 2002 Jan; 20(1):36-42. PubMed ID: 11742676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene targeting: the beginning of a new era in genetics].
    Teng Y; Yang X
    Yi Chuan; 2007 Nov; 29(11):1291-8. PubMed ID: 17989037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation gene targeting in the mouse for functional genomics.
    Gondo Y; Fukumura R; Murata T; Makino S
    BMB Rep; 2009 Jun; 42(6):315-23. PubMed ID: 19558788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Specificity of the CRISPR/Cas9 System.
    Tasan I; Zhao H
    ACS Synth Biol; 2017 Sep; 6(9):1609-1613. PubMed ID: 28911233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering the mouse genome to model human disease for drug discovery.
    Koentgen F; Suess G; Naf D
    Methods Mol Biol; 2010; 602():55-77. PubMed ID: 20012392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi: for functional analysis and target validation.
    Rondinone CM
    Expert Opin Ther Targets; 2006 Apr; 10(2):337-40. PubMed ID: 16548782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse genetics/genomics: an effective approach for drug target discovery and validation.
    West DB; Iakougova O; Olsson C; Ross D; Ohmen J; Chatterjee A
    Med Res Rev; 2000 May; 20(3):216-30. PubMed ID: 10797467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering chromosomal rearrangements in mice.
    Yu Y; Bradley A
    Nat Rev Genet; 2001 Oct; 2(10):780-90. PubMed ID: 11584294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of genomics to identify novel therapeutic targets.
    Orth AP; Batalov S; Perrone M; Chanda SK
    Expert Opin Ther Targets; 2004 Dec; 8(6):587-96. PubMed ID: 15584864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress of application and off-target effects of CRISPR/Cas9.
    Zheng W; Gu F
    Yi Chuan; 2015 Oct; 37(10):1003-10. PubMed ID: 26496752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating human genetics into mouse: the impact of ultra-rapid in vivo genome editing.
    Aida T; Imahashi R; Tanaka K
    Dev Growth Differ; 2014 Jan; 56(1):34-45. PubMed ID: 24444057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-NIH neuroscience initiatives on mouse phenotyping and mutagenesis.
    Moldin SO; Farmer ME; Chin HR; Battey JF
    Mamm Genome; 2001 Aug; 12(8):575-81. PubMed ID: 11471049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the human condition: experimental strategies in mammalian genetics.
    Paigen K
    ILAR J; 2002; 43(3):123-35. PubMed ID: 12105380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent innovations in tissue-specific gene modifications in the mouse.
    Furuta Y; Behringer RR
    Birth Defects Res C Embryo Today; 2005 Mar; 75(1):43-57. PubMed ID: 15838923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene trap mutagenesis.
    Abuin A; Hansen GM; Zambrowicz B
    Handb Exp Pharmacol; 2007; (178):129-47. PubMed ID: 17203654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of nuclease-mediated site-specific genome modification.
    Wirt SE; Porteus MH
    Curr Opin Immunol; 2012 Oct; 24(5):609-16. PubMed ID: 22981684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Welcome to the genomic era.
    Guttmacher AE; Collins FS
    N Engl J Med; 2003 Sep; 349(10):996-8. PubMed ID: 12954750
    [No Abstract]   [Full Text] [Related]  

  • 18. RNAi screening for the discovery of novel modulators of human disease.
    Seyhan AA; Rya TE
    Curr Pharm Biotechnol; 2010 Nov; 11(7):735-56. PubMed ID: 20420566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome engineering at the dawn of the golden age.
    Segal DJ; Meckler JF
    Annu Rev Genomics Hum Genet; 2013; 14():135-58. PubMed ID: 23701416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TALEN-mediated genome engineering to generate targeted mice.
    Sommer D; Peters AE; Baumgart AK; Beyer M
    Chromosome Res; 2015 Feb; 23(1):43-55. PubMed ID: 25596827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.